With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|MTG-16 Regulation by Phosphorylation||Vanderbilt University Medical Center / Michael Engel, MD, PhD||Young Investigator Grants||2006||Tennessee|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Identifying Epistatic Suppressors of Oncohistone in Pediatric High-Grade Gliomas||BC Cancer (Provincial Health Services Authority) / Carol Chen, PhD||Young Investigator Grants||2020||British Columbia|
|Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML||Fred Hutchinson Cancer Research Center / Phoenix Ho||Young Investigator Grants||2012||Washington|
|Investigating Racial Disparities in Pediatric Acute Leukemia||University of California San Francisco / Lena Winestone, MD||Young Investigator Grants||2016||California|
|Elucidating the Role of N-Myc in a High-risk Pediatric T Cell Leukemia||New York University School of Medicine / Francesco Boccalatte, PhD||Young Investigator Grants||2017||New York|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|
|GPC2 CAR T Cell Targeted Delivery of BiKEs in High-Risk Neuroblastoma||Children's Hospital of Philadelphia / Guillem Pascual-Pasto, PhD||Young Investigator Grants||2020||Pennsylvania|